Donald W. Wyatt
Gründer bei The Wyatt Group LLC
Aktive Positionen von Donald W. Wyatt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Wyatt Group LLC | Gründer | 01.01.2009 | - |
Corporate Officer/Principal | 01.01.2009 | - |
Karriereverlauf von Donald W. Wyatt
Ehemalige bekannte Positionen von Donald W. Wyatt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Direktor/Vorstandsmitglied | 19.12.2011 | 23.10.2013 |
Independent Dir/Board Member | 25.07.2012 | 23.10.2013 | |
AURINIA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 07.12.2011 | - |
Independent Dir/Board Member | 07.12.2011 | 27.01.2015 | |
CTI BIOPHARMA CORP. | Unternehmenssekretär | - | - |
Ausbildung von Donald W. Wyatt
Hampshire College | Graduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Kanada | 3 |
Operativ
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Corporate Secretary | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AURINIA PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
The Wyatt Group LLC | Miscellaneous |
- Börse
- Insiders
- Donald W. Wyatt
- Erfahrung